| 31st week of 2022 patent applcation highlights part 26 |
| Patent application number | Title | Published |
|---|
| 20220242934 | ANTIGEN-BINDING MOLECULE CONTAINING MODIFIED FC REGION - The present inventors have successfully prepared an antibody Fc region dimer that has binding activity against each of an antigen and FcγR, but does not bind to the antigen and the FcγR at the same time, and a polypeptide comprising the Fc region dimer. The present invention enables the preparation of a multispecific binding polypeptide capable of avoiding an adverse reaction that may be caused by its binding to an antigen and FcγR at the same time. Thus, the present invention provides a polypeptide suitable as a drug. | 2022-08-04 |
| 20220242935 | PAN-NEURAMINIDASE INHIBITING ANTIBODIES - The present invention relates to antibodies against influenza neuraminidase, compositions containing the antibodies and methods of using the antibodies. | 2022-08-04 |
| 20220242936 | HUMANIZED ANTI-A[BETA] MONOCLONAL ANTIBODY AND APPLICATION THEREOF - Provided are a humanized anti-Aβ monoclonal antibody and use thereof. The humanized anti-Aβ monoclonal antibody provided can inhibit the polymerization of Aβ monomers, protect nerve cells from the toxicity of Aβ, and have a certain effect on improving the cognitive learning and memory ability of Alzheimer's dementia model mice, and can be used for the treatment and diagnosis of diseases and disorders related to amyloidosis, such as Alzheimer's disease. | 2022-08-04 |
| 20220242937 | HUMANIZED ANTI-A[BETA] MONOCLONAL ANTIBODY AND APPLICATION THEREOF - Provided are a humanized anti-Aβ monoclonal antibody and use thereof. The humanized anti-Aβ monoclonal antibody provided can inhibit the polymerization of Aβ monomers, protect nerve cells from the toxicity of Aβ, and have a certain effect on improving the cognitive learning and memory ability of Alzheimer's dementia model mice, and can be used for the treatment and diagnosis of diseases and disorders related to amyloidosis, such as Alzheimer's disease. | 2022-08-04 |
| 20220242938 | Anti-Polyubiquitin Multispecific Antibodies - The invention provides antibodies that bind mixed-topology polyubiquitin and multispecific anti-polyubiquitin antibodies, and methods of using the same. | 2022-08-04 |
| 20220242939 | ANTIBODY DIRECTED AGAINST THE APOE AMINO-TERMINAL FRAGMENT OF 12KDA - The disclosure relates to an antibody or antigen binding portion thereof, which binds to a neo-epitope of a C-terminal fragment of apolipoprotein E, to methods of producing such an antibody or antigen binding portion thereof, and to therapeutic and diagnostic uses thereof. | 2022-08-04 |
| 20220242940 | Anti-Abeta Antibodies - Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided. | 2022-08-04 |
| 20220242941 | ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF - Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a parasite population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and V | 2022-08-04 |
| 20220242942 | GDF-15 AS A DIAGNOSTIC MARKER TO PREDICT THE CLINICAL OUTCOME OF A TREATMENT WITH IMMUNE CHECKPOINT BLOCKERS - The present invention relates to methods for predicting the probability of a treatment response of a human cancer patient to an immune checkpoint blocker treatment e.g. with anti PD-1, and to methods for predicting the probability of survival of a human cancer patient following an immune checkpoint blocker treatment, and to apparatuses and kits which can be used in these methods. | 2022-08-04 |
| 20220242943 | ANTI- PDGF-B ANTIBODIES AND METHODS OF USE FOR TREATING PULMONARY ARTERIAL HYPERTENSION (PAH) - The present disclosure provides anti-Platelet-Derived Growth Factor Subunit B (PDGF-B) antibodies, and antigen-binding fragments thereof, as well as methods of use of such antibodies, or antigen-binding fragments thereof, for treating a subject having pulmonary arterial hypertension (PAH). | 2022-08-04 |
| 20220242944 | ANTIGEN BINDING MOLECULES THAT BIND PDGF-B AND PDGF-D AND USES THEREOF - The present invention provides antigen-binding molecules or antibodies which specifically bind to PDGF-B and/or PDGF-D. The invention further relates to compositions and therapeutic methods for using these antigen-binding molecules or antibodies for the treatment and/or prevention of PDGF-mediated diseases, disorders, or conditions. | 2022-08-04 |
| 20220242945 | POLYPEPTIDES - There is provided inter alia a polypeptide comprising an immunoglobulin chain variable domain which binds to IL-23, wherein the immunoglobulin chain variable domain comprises three complementarity determining regions (CDR1-CDR3) and four framework regions (FR1-FR4), wherein CDR1 comprises a sequence sharing 60% or greater sequence identity with SEQ ID NO: 1, CDR2 comprises a sequence sharing 50% or greater sequence identity with SEQ ID NO: 2 and CDR3 comprises a sequence sharing 50% or greater sequence identity with SEQ ID NO: 3. | 2022-08-04 |
| 20220242946 | METHODS AND MATERIALS FOR TARGETED EXPANSION OF REGULATORY T CELLS - This document relates to methods and materials for targeted expansion of regulatory T cells (T | 2022-08-04 |
| 20220242947 | PROVASOPRESSIN ANTAGONISTS AND USES THEREOF - Provided herein are pro-VP antagonists, such as antibodies and antigen-binding portions thereof specific for pro-VP, for identifying and targeting expressing cancer cells. Applicants additionally provide methods of using said compositions, for example to image cancer cells in vivo and in biological samples. The compositions may also be used for treating patients suffering from a provasopressin-expressing cancer. Provasopressin-expressing cancers include neuroendocrine cancer, pancreatic cancer, and prostate cancer. | 2022-08-04 |
| 20220242948 | ANTI-L1CAM ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND CHIMERIC ANTIGEN RECEPTOR COMPRISING SAME - The present invention relates to an anti-L1CAM antibody specifically binding to L1CAM antigen or an antigen-binding fragment thereof, a chimeric antigen receptor comprising same, and uses thereof. The anti-L1CAM antibody or the antigen-binding fragment of the present invention is excellent in specificity and affinity to L1CAM and thus may be used in the treatment and diagnosis of cancers related to high expression of L1CAM and diseases related to inflammatory disorders. In particular, when the chimeric antigen receptor comprising the anti-L1CAM antibody of the present invention is expressed in effector cells such as T lymphocytes, the chimeric antigen receptor may be effectively used as immunotherapy for cancers related to L1CAM and inflammatory disorders. | 2022-08-04 |
| 20220242949 | ANTI-CD166 ANTIBODIES AND USES THEREOF - The present invention provides, among other things, an antibody or antigen-binding polypeptide that binds or is capable of binding CD166, compositions including the same, and uses thereof. In certain embodiments, an anti-CD166 antibody or antigen-binding polypeptide of the present invention binds or is capable of binding all or a portion of an intracellular domain (“ICD”) of CD166. The present invention also includes, among other things, a nucleic acid molecule encoding an antibody or antigen-binding polypeptide that binds or is capable of binding CD166. In various embodiments, an anti-CD166 antibody or antigen-binding polypeptide is useful in a method of detecting or treating a condition or disease. | 2022-08-04 |
| 20220242950 | Anti-IL1RAP antibody - The present invention relates to an antibody or antigen-binding fragment thereof with binding specificity for interleukin-1 receptor accessory protein (IL1RAP). Furthermore, it relates to a polynucleotide encoding said antibody, a vector comprising said polynucleotide and a recombinant host cell comprising said polynucleotide or said vector. Further, it relates to a method for producing said antibody or antigen-binding fragment. Further, it relates to a composition comprising said antibody or antigen-binding fragment, said polynucleotide, said vector and/or said host cell. Further, it relates to the said antibody or antigen-binding fragment, said polynucleotide, said vector, said host cell and/or said composition for use in medicine and/or for use in the prevention and/or treatment and/or alleviation and/or detection and/or diagnosis of a disease or disorder susceptible to treatment with an inhibitor of IL-1α, IL-1β, IL-33, IL-36α, IL-36β and/or IL-36γ signaling, and/or wherein the disease or disorder is associated with cells expressing IL1RAP. | 2022-08-04 |
| 20220242951 | USES OF ANTI-SIRPg ANTIBODIES - The invention pertains to the field of immunotherapy. The present invention provides new uses of anti-SIRPg antibodies for the treatment and/or the prevention of autoimmune disorders or diseases. | 2022-08-04 |
| 20220242952 | ANTI-CD19 THERAPY IN PATIENTS HAVING A LIMITED NUMBER OF NK CELLS - The present disclosure provides characteristics and biomarkers in patients that benefit from treatment with anti-CD19 antibodies (MOR00208, XmAb5574). Furthermore, the present application relates to anti-CD19 antibodies for the treatment of leukemia or lymphoma in patients having a peripheral NK cell count at baseline of less or equal to 100 NK cells/μl | 2022-08-04 |
| 20220242953 | CD3 ANTIBODY AND PHARMACEUTICAL USE THEREOF - The present disclosure relates to a CD3 antibody and a pharmaceutical use thereof. Specifically, the present disclosure relates to forming a multi-specificity antibody by using CD3 antibody and binding molecules of another target. The multi-specificity antibody may simultaneously bind to CD3 and another tumor-associated antigen, and bind and activate CD3-positive T cells while binding tumor-associated antigen-expressing cells, thereby promoting T cells specifically killing tumor cells that express tumor-associated antigens. In addition, the present disclosure also provides a preparation and application of a multi-specific antibody. | 2022-08-04 |
| 20220242954 | Antigen Binding Proteins that Bind PD-1 - There is disclosed compositions and methods relating to or derived from anti-PD-1 antibodies. More specifically, there is disclosed fully human antibodies that bind PD-1, PD-1-binding fragments and derivatives of such antibodies, and PD-1-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having PD-1 related disorders or conditions, including various inflammatory disorders and various cancers. | 2022-08-04 |
| 20220242955 | TARGETING GALECTIN-9 AS A THERAPEUTIC STRATEGY FOR T-CELL EXHAUSTION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA - The present invention relates to compositions and methods for treating early T-cell precursor acute lymphoblastic leukemia (ETP T-ALL). | 2022-08-04 |
| 20220242956 | ACTRII-BINDING PROTEINS AND USES THEREOF - This disclosure provides ActRII-binding proteins such as anti-ActRIIA and anti-ActRIIB antibodies, and compositions and methods for making the ActRII-binding proteins. In certain embodiments, the ActRII-binding proteins inhibit, or antagonize ActRII activity. In addition, the disclosure provides compositions and methods for diagnosing and treating diseases and conditions associated with muscle wasting; a fibrotic condition; an inflammatory, cardiovascular, pulmonary, musculoskeletal, neurologic, ocular, skeletal, autoimmune, or metabolic disease or condition; wound healing; and cancer, and other ActRII-mediated diseases and conditions. | 2022-08-04 |
| 20220242957 | CSF1R/CCR2 MULTISPECIFIC ANTIBODIES - Molecules, e.g., multispecific molecules, targeting CSF1R or CCR2 and methods of using the same, are disclosed. | 2022-08-04 |
| 20220242958 | BISPECIFIC NANOBODIES - The present disclosure relates to bispecific polypeptides comprising a first and a second immunoglobulin single variable domain (ISV), wherein said first ISV binds to a first target on the surface of a cancer cell with a low affinity and, when bound inhibits a function of said first target, and a said second ISV binds to a second target on the surface of said cell with a high affinity and wherein said first target is different from said second target. The present invention further discloses methods for identifying and making the same. | 2022-08-04 |
| 20220242959 | MODIFIED DOSAGE OF SUBCUTANEOUS TOCILIZUMAB FOR RHEUMATOID ARTHRITIS - The present disclosure relates the dosage modification and choice of an IL6 antibody for the treatment of rheumatoid arthritis in subjects. | 2022-08-04 |
| 20220242960 | GHR-106 CHIMERIC ANTIGEN RECEPTOR CONSTRUCT AND METHODS OF MAKING AND USING SAME - A chimeric antigen receptor (CAR) having an antigen binding domain capable of binding to extracellular domains of human GnRH receptor. The antigen binding domain can have a binding affinity and specificity similar to the GHR-106 antibody. Methods of making and using such CARs are provided. The CARs can be used to treat cancer. | 2022-08-04 |
| 20220242961 | ANTI-4-1BB ANTIBODY AND USE THEREOF - Provided is an anti-4-1 BB antibody or an antigen-binding fragment thereof, and uses thereof. | 2022-08-04 |
| 20220242962 | 4-1BB AND OX40 BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS, ANTIBODIES AGAINST 4-1BB, ANTIBODIES AGAINST OX40 - The present disclosure provides antibodies that specifically bind to 4-1BB and/or OX40, including bispecific antibodies that bind to 4-1BB and OX40, and compositions comprising such antibodies. Also provided are methods for treating disorders, such as cancer, using such antibodies and compositions. | 2022-08-04 |
| 20220242963 | B-CELL ACTIVATING CD73 ANTIBODIES - Provided herein are, inter alia, methods and compositions using and including anti-CD73 antibodies capable of activating B cells, and affecting the redistribution of B cells from lymphoid tissues to lymphoid organs This previously unknown and unique effect of anti-CD73 antibodies may be useful for the treatment of various indications, for example, enhancing immunity to immunogenic cancers, treating autoimmune disease (e.g., multiple sclerosis), inflammatory diseases, or infectious disease. | 2022-08-04 |
| 20220242964 | COMPOSITIONS AND METHODS FOR REGULATING ERYTHROPOIESIS - The present application discloses a previously unknown function of CD24 expressed on a subset of dendritic cells. The invention encompasses regulating CD24 on these cells to regulate erythropoiesis, induce EPO production and levels, increase RBC levels, and to treat, for example, stress-mediated erythropoiesis. The compositions and methods of the invention are useful, for example, in treating anemia. | 2022-08-04 |
| 20220242965 | ENGINEERED T-CELLS CO-EXPRESSING AN ANTI-BCMA CAR AND AN ANTI-ECTOENZYME ANTIBODY AND THEIR USE IN THE TREATMENT OF CANCER - The present invention provides a cell which expresses a chimeric antigen receptor (CAR) or engineered T-cell receptor (TCR) and secretes an agent which blocks or reduces the activity of an ectoenzyme. The cells may be used in adoptive immunotherapy approaches for the treatment of diseases such as cancer. | 2022-08-04 |
| 20220242966 | CD63 AGONIST-RELATED METHODS AND COMPOSITIONS - Provided are methods of treating cell proliferative disorders. In some embodiments, the methods include administering to a subject having a cell proliferative disorder a therapeutically effective amount of a CD63 agonist, where the CD63 agonist is administered to the subject to enhance a T cell response to abnormally proliferating cells of the cell proliferative disorder. In certain embodiments, the methods include administering to a subject having a cell proliferative disorder a therapeutically effective amount of a CD63 agonist and a therapeutically effective amount of a T cell activator. Also provided are pharmaceutical compositions and kits that find use, e.g., in practicing the methods. | 2022-08-04 |
| 20220242967 | ANTI-GLYPICAN-3 ANTIBODIES AND USES THEREOF - The present disclosure relates generally to immunoglobulin-related compositions (e.g., antibodies or antigen binding fragments thereof) that can bind to the Glypican-3 (GPC3) protein. The antibodies of the present technology are useful in methods for detecting and treating GPC3-associated cancers in a subject in need thereof. | 2022-08-04 |
| 20220242968 | Anti-CEACAM5 monoclonal antibody and preparation method thereof and use thereof - Disclosed are a monoclonal antibody and antigen-binding fragment thereof which can specifically bind to human carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5); also disclosed is a chimeric antigen receptor based on said antibody, and a method for preparing said antibody and antigen-binding fragment and use thereof for treating CEACAM5-related tumors. | 2022-08-04 |
| 20220242969 | ANTIBODY POLYPEPTIDES AND USES THEREOF - The present invention provides antibody polypeptides with binding specificity for prostate specific antigen (PSA), wherein the antibody polypeptide comprises (a) a heavy chain variable region comprising the amino acid sequences of SEQ ID NO:1 and SEQ ID NO:2 and SEQ ID NO:3 and/or (b) a light chain variable region comprising the amino acid sequences of SEQ ID NO:4 and SEQ ID NO:5 and SEQ ID NO:6, and wherein the heavy chain variable region and light chain variable region comprise framework amino acid sequences from one or more human antibodies. The invention further provides use of said antibody polypeptides in the diagnosis and treatment of prostate cancer | 2022-08-04 |
| 20220242970 | GLYCAN-BASED ANTIBODY-DRUG CONJUGATES - Genetically engineered antibodies containing non-native N-glycosylated sites, preparation of the antibodies in yeast and fungi, site-specific conjugation of drugs to these antibodies, and methods of treatment utilizing these antibodies are described herein. | 2022-08-04 |
| 20220242971 | NOVEL IMMUNOCONJUGATES - The present invention generally relates to antigen-specific immunoconjugates for selectively delivering effector moieties that influence cellular activity. More specifically, the invention provides novel immunoconjugates comprising a first antigen binding moiety, an Fc domain and a single effector moiety. In addition, the present invention relates to polynucleotides encoding such immunoconjugates, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the immunoconjugates of the invention, and to methods of using these immunoconjugates in the treatment of disease. | 2022-08-04 |
| 20220242972 | Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria - In one aspect, the invention provides methods and compositions for inhibiting MASP-3-dependent complement activation in a subject suffering from paroxysmal nocturnal hemoglobinuria by administering to the subject a composition comprising an amount of a MASP-3 inhibitory agent in an amount effective to inhibit MASP-3-dependent complement activation. In another aspect, the invention provides methods and compositions for increasing the survival of red blood cells in a subject suffering from paroxysmal nocturnal hemoglobinuria by administering to the subject a composition comprising an amount of at least one of a MASP-1 inhibitory agent and/or a MASP-3 inhibitory agent effective to increase the survival of red blood cells. In some embodiments, the subject is administered a MASP-2 inhibitory agent and a MASP-1 inhibitory agent, a MASP-2 inhibitory agent and a MASP-3 inhibitory agent administered, a MASP-3 inhibitory agent and a MASP-1 inhibitory agent, or a MASP-1 inhibitory agent, a MASP-2 inhibitory agent and a MASP-3 inhibitory agent. | 2022-08-04 |
| 20220242973 | RECOMBINANT FAP BINDING PROTEINS AND THEIR USE - The present disclosure relates to recombinant binding proteins comprising a designed ankyrin repeat domain with binding specificity for fibroblast activation protein (FAP). In addition, the disclosure relates to nucleic acids encoding such binding proteins, pharmaceutical compositions comprising such binding proteins or nucleic acids, and the use of such binding proteins, nucleic acids or pharmaceutical compositions in methods for localizing or delivering a biologically active molecule in FAP-expressing tissue, such as tumor tissue, and for treating, diagnosing or imaging diseases, such as cancer, in a mammal, including a human. | 2022-08-04 |
| 20220242974 | ANTI-PD-L1 NANOBODY AND FC FUSION PROTEIN AND APPLICATION THEREOF - Provided are an anti-PD-L1 nanobody and an Fc fusion protein thereof, and an application thereof. The anti-PD-L1 nanobody and the Fc fusion protein thereof have strong specificity, high affinity, and weak immunogenicity to humans. In addition, same have high stability and a significant anti-tumor effect. | 2022-08-04 |
| 20220242975 | IMMUNOGLOBULIN-BINDING PROTEIN AND AFFINITY SUPPORT USING SAME - An affinity support having improved binding capacity for target proteins. An immunoglobulin-binding protein including a mutant immunoglobulin-binding domain, an affinity support including a solid-phase support and the immunoglobulin-binding protein immobilized thereto. The mutant immunoglobulin-binding domain consists of an amino acid sequence having at least 85% identity with an amino acid sequence of any of SEQ ID NOs: 1 to 12. | 2022-08-04 |
| 20220242976 | PROCESS FOR PREPARING CATALYSTS AND CATALYST COMPOSITIONS - Disclosed are support-activators and catalyst compositions comprising the support-activators for polymerizing olefins in which the support-activator includes clay heteroadduct, prepare from a colloidal phyllosilicate such as a colloidal smectite clay, which is chemically-modified with a heterocoagulation agent. By limiting the amount of heterocoagulation reagent relative to the colloidal smectite clay as described herein, the smectite heteroadduct support-activator is a porous and amorphous solid which can be readily isolated from the resulting slurry by a conventional filtration process, and which can activate metallocenes and related catalysts toward olefin polymerization. Related compositions and processes are disclosed. | 2022-08-04 |
| 20220242977 | Hybrid Supported Metallocene Catalyst and Process for Preparing Polyethylene Copolymer Using the Same - The present disclosure provides a hybrid supported metallocene catalyst useful for preparing a polyethylene copolymer exhibiting excellent process stability and high polymerization activity in ethylene polymerization, and excellent mechanical properties by high comonomer incorporation. The hybrid supported metallocene catalyst comprises at least one first metallocene compound selected from compounds represented by the following Chemical Formula 1; and at least one second metallocene compound selected from compounds represented by the following Chemical Formula 2: | 2022-08-04 |
| 20220242978 | CURABLE COMPOSITION, AND RESIN COMPOSITION FOR STEREOLITHOGRAPHY PREPARED THEREFROM - To provide a curable composition that is readily modeled with low viscosity and excellent curing capability in modeling by stereolithography, and provides a cured article excellent in toughness and water resistance, and a resin composition for stereolithography prepared therefrom. To provide a resin composition for stereolithography that is favorable particularly for a dental mouthpiece and a denture base material. A curable composition containing 79.0 to 99.0% by mass of a polymerizable monomer (a), 0.1 to 10.0% by mass of a photopolymerization initiator (b), and 0.01 to 20.0% by mass of a compound (c) represented by the following general formula (I): | 2022-08-04 |
| 20220242979 | METHOD FOR PRODUCING CHLOROPRENE-BASED-POLYMER LATEX - A method for producing a chloroprene-based polymer latex which can efficiently remove a residual volatile organic substance from the chloroprene-based polymer latex while suppressing the deposition of agglomerates is provided. In the method for producing a chloroprene-based polymer latex of the present invention, when the residual volatile organic substance comprised in the latex is volatilized and removed, a mixed fluid of one or more gases selected from the group consisting of inert gases and air, and water is contacted with the latex at a gas pressure higher than the saturated water vapor pressure, and a temperature of the mixed fluid is a temperature lower than a boiling point of water at the gas pressure. | 2022-08-04 |
| 20220242980 | Method for Producing Ethylene-Carboxylic Acid Copolymer - In a method of producing an ethylene-carboxylic acid copolymer according to an embodiment of the present invention, a carboxylic acid monomer and a polar co-solvent are introduced separately into a mixing unit or stored together in a supply unit to form a mixture. The mixture and ethylene are injected into a reactor to be copolymerized. Reaction kinetic properties of the carboxylic acid monomer and the polar co-solvent are controlled to suppress a formation of by-products. | 2022-08-04 |
| 20220242981 | RESIN FOR FILM-SHAPED MOLDED BODY AND MOLDED PRODUCT COMPRISING SAME - This is a resin composition for a film containing an ionomer which comprises, in a copolymer (P) containing a structural unit (A) derived from ethylene and/or an α-olefin having 3 to 20 carbon atoms, and a structural unit (B) derived from a monomer having a carboxyl group(s) and/or a dicarboxylic anhydride group(s) as essential constitutional units, at least a part of the carboxyl groups and/or the dicarboxylic anhydride groups in the copolymer (P) being converted into a metal-containing carboxylic acid salt(s) containing at least one kind of a metal ion(s) selected from Group 1, Group 2 or Group 12 of the periodic table, and having a phase angle δ at an absolute value G*=0.1 MPa of a complex modulus of elasticity measured by a rotary rheometer of 50 degrees to 75 degrees, and a molded body molded by using the same. | 2022-08-04 |
| 20220242982 | ACTIVATABLE ADHESIVE COMPOSITIONS AND LINERLESS LABELS AND TAPES COMPRISING SAME - Activatable adhesive compositions are disclosed. The activatable adhesive compositions comprise a two-stage polymer particle, comprising a first stage comprising a hydrophilic acrylic polymer having an acid content of less than 200 mg KOH/g, a second stage polymerized within the first stage and comprising a hydrophobic acrylic polymer, and a tackifier soluble in the first stage and the second stage. Further, linerless labels and tapes comprising activatable adhesive compositions are disclosed. Still further, methods for adhering a first substrate to a second substrate using an activatable adhesive composition are also disclosed. | 2022-08-04 |
| 20220242983 | POLYMERS AND METHODS FOR OPHTHALMIC APPLICATIONS - Novel methods and materials particularly useful for ophthalmic applications and to methods for making and using the same are disclosed herein. More particularly, relatively soft, optically transparent, foldable, high refractive index materials particularly suited for use in the production of intraocular lenses, contact lenses, and other ocular implants and to methods for manufacturing and implanting IOLs made therefrom are disclosed. | 2022-08-04 |
| 20220242984 | COMPOSITION, METHOD OF PRODUCING POLYMER USING THE COMPOSITION, AND POLYMER PRODUCED THEREBY - Provided are a composition including a monomer, a photoinitiator, and a cross-linking agent, the composition having a viscosity suitable for inkjet coating at room temperature, wherein a polymer produced through cross-linking of the compound has a modulus value at 60° C. (G′ | 2022-08-04 |
| 20220242985 | PHOTOSENSITIVE COMPOSITION, HOLOGRAM RECORDING MEDIUM USING THE SAME, HOLOGRAM OPTICAL ELEMENT, AND METHOD OF FORMING HOLOGRAM DIFFRACTION GRATING - To provide a photosensitive composition capable of further improving diffraction characteristics. | 2022-08-04 |
| 20220242986 | SHAPE MEMORY RESIN, ARTICLE FOR EXTERNAL USE ON SKIN, AND METHOD FOR PRODUCING ARTICLE FOR EXTERNAL USE ON SKIN - A shape memory resin includes a polymer comprising 64-85 mol % N-alkylacrylamide component, 14-35 mol % acrylic ester component, and 0.01-6 mol % crosslinking component. | 2022-08-04 |
| 20220242987 | CHLOROPRENE COPOLYMER LATEX COMPOSITION AND MOLDED ARTICLE OF SAME - The present invention relates to a chloroprene copolymer latex composition, a molded article of chloroprene copolymer rubber, or a dip-molded product, and the chloroprene copolymer latex composition includes a chloroprene copolymer (A) and a vulcanization accelerator (B). The chloroprene copolymer (A) includes monomer units derived from chloroprene and from 2-methyl-1,3-butadiene. The chloroprene copolymer latex composition includes a carbamate-based vulcanization accelerator and a thiazole-based vulcanization accelerator as the vulcanization accelerator (B). The chloroprene copolymer latex composition enables production of a molded article having high flexibility and high tensile strength without use of a vulcanization accelerator that is feared to have skin sensitization. | 2022-08-04 |
| 20220242988 | Polymer Gels In The Formation Of Polymer Brushes - The present invention relates to the use of polymer gels in the preparation of polymer brushes. In particular, the present invention relates to polymer gels swelled in the polymerisation medium. The invention further relates to the use of polymer gels in the formation of polymer brushes on a surface. The present invention provides improved methods for forming polymer brushes on a surface, thus, enabling easy large-scale production of polymer brush-coated surfaces. In particular, the present invention enables application of the polymerisation medium on surfaces of all geometries. | 2022-08-04 |
| 20220242989 | Bacteria Repellant Polymer Composites - Provided herein is a masterbatch including a grafted silicone polyether and a porous inorganic nanoparticle, bacteria repellant polymer composites including the same, and methods of preparation thereof. | 2022-08-04 |
| 20220242990 | PREPARATION METHOD OF SUPER ABSORBENT POLYMER - The present disclosure relates to a preparation method of a super absorbent polymer. More specifically, it relates to a preparation method of a super absorbent polymer capable of significantly reducing the amount of fine powder generated during the process by mixing a hydrogel polymer with an additive having a specific structure, pulverizing it, and then drying it with a paddle-type dryer. | 2022-08-04 |
| 20220242991 | Orthodontic Articles Comprising Polymerized Composition with Pendent Cyclic Moieties, Methods, and Polymerizable Compositions - Polymerizable compositions suitable for use for 3D printed (e.g. orthodontic) articles, especially orthodontic alignment trays, are described. The polymerizable composition comprises a) 30-70 parts by weight of (meth)acrylate monomer(s); and b) urethane (meth)acrylate polymer; wherein the reaction product comprises at least 1 wt. % polymerized units of a multifunctional compound comprising pendent cyclic moieties. The orthodontic article comprises the reaction product of a polymerizable composition as described herein. The urethane (meth)acrylate polymer typically comprises polymerized units of a multifunctional compound comprising pendent cyclic moieties and/or at least one (meth)acrylate monomer comprises polymerized units of a multifunctional compound comprising pendent cyclic moieties. Also described are methods of making an article, non-transitory machine-readable medium comprising data representing a three-dimensional model of an article, and systems. | 2022-08-04 |
| 20220242992 | LIGHT PATTERNING OF INORGANIC MATERIALS - Compositions including a plurality of reactive components. The reactive components each include an inorganic core with one or more photoresponsive ligand(s) covalently bonded to a surface of the inorganic core. A composition may also include a photoinitiator. Methods of making an article of manufacture includes photochemically reacting at least a portion of one or more layer(s) formed from one or more composition(s). The photochemical reaction may be carried using a laser as a source of electromagnetic radiation. An article of manufacture, which may be a three-dimensional article of manufacture, may be or is a part of a microfluidic device, HPLC column, fluidic channel, point of care device, or diagnostics device. | 2022-08-04 |
| 20220242993 | AMPHIPHILIC BRANCHED COPOLYMER DRILLING ADDITIVE - An amphiphilic branched star polymer drilling additive includes a crosslinked, polymerized reaction product of crosslinker C, hydrophobic monomer B, and hydrophilic monomer A. The crosslinked polymerized reaction product includes a plurality of block copolymer segments of hydrophobic monomer B and hydrophilic monomer A interconnected via crosslinker C. | 2022-08-04 |
| 20220242994 | Block copolymer with improved resistance to sebum - The present invention concerns the use of PCL in preparing a block copolymer comprising at least one rigid block and at least one flexible block, for enhancing the sebum resistance of said block copolymer. | 2022-08-04 |
| 20220242995 | AMINO RESIN PERFORMANCE WITH SULFONATED LIGNIN - A resin system and methods of making resin system wherein lignosulfonate is added to urea-formaldehyde and melamine-urea-formaldehyde adhesives. Lignosulfonate is added to the resins which improves the performance characteristics of the adhesive while reducing environmental impact by consuming byproducts from other industrial processes. The resin system includes a urea-formaldehyde (UF) resin or melamine-urea-formaldehyde (MUF), prepared in at least two stages wherein the UF resin or MUF resin has a molar ratio (MR) of total moles formaldehyde to total moles urea plus, if present, the one or more melamine compounds of from about 0.25:1 to about 2.50:1, and wherein one or more lignosulfonate compounds are included in an amount of from about 0.1-30 wt. %, based on a total weight of the resin system, and wherein the resin system has a buffer capacity of 2-400 mL of 0.1 N HCl by the ATV Method for a period of time of at least about 20 days at 25° C. | 2022-08-04 |
| 20220242996 | WATER-EMULSIFIABLE ISOCYANATES WITH IMPROVED PROPERTIES - A process for producing a water-emulsifiable polyisocyanate formulation, in which, in a first process step, | 2022-08-04 |
| 20220242997 | A REACTIVE COMPOSITION FOR POLYURETHANE FOAM AND USE THEREOF IN AUTOMOBILE PARTS - Described herein are a reactive composition, a semi-rigid polyurethane foam obtained therefrom, a filled cavity, and a method of use thereof in automobile parts. | 2022-08-04 |
| 20220242998 | IMPROVED THERMOPLASTIC POLYURETHANES - Provided herein are novel thermoplastic polyurethanes having improved qualities such as reduced film haze and high transparency, together with methods for producing the same. The thermoplastic polyurethanes disclosed herein are obtainable or obtained by reaction of (i) at least one aliphatic polyisocyanate, (ii) at least one polyol, (iii) at least one chain extender, and (iv) a sorbitol-based clarifying agent, wherein a content of the sorbitol-based clarifying agent is predetermined relative to a total weight of the components (i) to (iii). | 2022-08-04 |
| 20220242999 | METHODS OF USING THERMOPLASTIC POLYURETHANES IN SELECTIVE LASER SINTERING AND SYSTEMS AND ARTICLES THEREOF - The present invention relates to systems and methods for solid freeform fabrication, especially selective laser sintering, as well as various articles made using the same, where the systems and methods utilize certain thermoplastic polyurethanes which are particularly suited for such processing. The useful thermoplastic polyurethanes are derived from (a) a polyisocyanate component, (b) a polyol component, and (c) an optional chain extender component; wherein the resulting thermoplastic polyurethane has a melting enthalpy of at least 5.5 J/g, a Tc (crystallization temperature) of more than 70° C., a Δ(Tm:Tc) of from 20 to 75 degrees, where Δ(Tm:Tc) is the difference between the Tm (melting temperature) and Tc. | 2022-08-04 |
| 20220243000 | POLYURETHANE COMPOSITION FOR THE MANUFACTURE OF FLOORS, ESPECIALLY FOR MARINE APPLICATIONS - A polyurethane composition comprising: a) a polyol component including: at least one reaction product of castor oil with ketone resins having an OH number of 110 to 200 mg KOH/g; and at least one aliphatic triol, and b) an polyisocyanate component including: at least one polyisocyanate resin based on hexamethylene diisocyanate comprising one or more polyisocyanate prepolymers derived from the uretdione, the biuret or the isocyanurate of hexamethylene diisocyanate (HDI) blended with a member of the group consisting of the uretdione, the biuret or the isocyanurate of HDI, wherein weight ratio of the polyol o the polyol is in the range of 1.25-2.5. The invention provides curable flooring compositions that display good adhesion and proper mechanical performance, provide a Shore A hardness of 55-70, after curing, produce a nice appeal upon sanding cured composition and quickly regain the original form after load has been placed on the cured material. | 2022-08-04 |
| 20220243001 | EPOXY RESIN COMPOSITION - Provided is an epoxy resin composition that gives a cured product having excellent adhesion to metal and low dielectric characteristics, and that has good workability during use and high storage stability. Specifically, provided is an epoxy resin composition comprising a specific epoxy resin and a specific phenol-based curing agent. | 2022-08-04 |
| 20220243002 | LONG SHELF LIFE STABLE PHOTOACTIVE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS - Embodiments in accordance with the present invention encompass compositions encompassing a latent organo-ruthenium compound, a photosensitizer and one or more monomers which undergo ring open metathesis polymerization (ROMP) when said composition is exposed to suitable actinic radiation to form a substantially transparent film or a three dimensional object. Surprisingly, the compositions are very stable at ambient conditions to temperatures up to 80° C. for several weeks and undergo mass polymerization only when subjected to actinic radiation under inert atmosphere such as for example a blanket of nitrogen. Accordingly, compositions of this invention are useful in various opto-electronic applications, including as 3D printing materials, coatings, encapsulants, fillers, leveling agents, among others. | 2022-08-04 |
| 20220243003 | PREPARATION METHOD OF POLYMER - The present application can provide a preparation method that can effectively produce a polymer having desired molecular weight characteristics and solubility in a solvent, and having a monomer composition, which is designed freely and variously according to the purpose, without unnecessary components with excellent polymerization efficiency and conversion rates, and a dispersion comprising the polymer formed by the preparation method. | 2022-08-04 |
| 20220243004 | Polymer Composition for an Electric Circuit Protection Device - A polymer composition for use in an electric circuit protection device is provided. The polymer composition comprises a polymer matrix that includes a thermotropic liquid crystalline polymer. The polymer composition exhibits an in-plane thermal conductivity of about 3.5 W/m-K or more as determined in accordance with ASTM E1461-13 and a melt viscosity of from about 1 to about 100 Pa-s as determined in accordance with ISO Test No. 11443:2014 at a temperature 15° C. higher than the melting temperature. | 2022-08-04 |
| 20220243005 | BIODEGRADABLE RESIN COMPOSITION HAVING IMPROVED MECHANICAL PROPERTY, FORMABILITY, AND WEATHERPROOF AND METHOD FOR MANUFACTURING THE SAME - The present invention relates to a biodegradable resin composition having improved mechanical properties, formability and weatherproof, and a method for manufacturing the biodegradable resin composition. More specifically, the biodegradable resin composition according to the present invention is obtained by mixing an aliphatic dicarboxylic acid or an acid component comprising a mixture of an aliphatic dicarboxylic acid and an aromatic dicarboxylic acid, and aliphatic diol, and subjecting the mixture sequentially to esterification, transesterification, polycondensation, chain extension and solid-state polymerization reactions in the presence of a polyfunctional compound, and may have improved productivity and economic efficiency due to improved reaction rate, excellent tensile strength, elongation rate and processability. In addition, the biodegradable resin composition according to the present invention is environmentally friendly as it is biodegradable in a natural state when buried. | 2022-08-04 |
| 20220243006 | COPOLYESTERS OF 2,4-FDCA WITH INCREASED CRYSTALLIZATION CONTROL - The present disclosure provides a copolyester including a dicarboxylic acid component A comprising a terephthalic acid residue or ester-forming derivative thereof, or a mixture thereof, and a 2,4-furandicarboxylic acid residue or ester-forming derivative thereof, or a mixture thereof, and a diol component B comprising an alkanediol residue having from 2 to 22 carbon atoms, wherein the dicarboxylic acid component A has a total molar content, and wherein the 2,4-furandicarboxylic acid residue or ester-forming derivative thereof, is present in an amount of from 0.1 to 10 mol %, with respect to the total molar content of the dicarboxylic acid component A. Inventive copolyesters have a slower crystallization rate, a higher gas barrier to CO | 2022-08-04 |
| 20220243007 | POLYMER MATERIAL AND METHOD FOR PRODUCING SAME - A polymer material consists of expanded polyethylene terephthalate with a density of 30 kg/m | 2022-08-04 |
| 20220243008 | THERMOPLASTIC RESIN, METHOD FOR MANUFACTURING SAME, AND OPTICAL LENS - Crystalline solvate forms and amorphous forms of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl, where the organic solvent is selected from methanol, toluene, and methyl ethyl ketone, and an amorphous form of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl having a purity of at least 99.0% by weight, based on organic matter. Thermoplastic resins containing a structural unit derived from 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl. Optical lenses containing the thermoplastic resins containing a structural unit derived from 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl. | 2022-08-04 |
| 20220243009 | MULTI-ARMED POLYMERS COMPRISING FREE-RADICAL-POLYMERIZABLE MONOMERS AND COMPOSITIONS, SYSTEMS AND METHODS PERTAINING TO THE SAME - In some aspects, the present disclosure pertains to multi-arm polymers that comprise a core, a plurality of polymer segments having a first end that is covalently attached to the core and a second end comprising a moiety that comprises a reactive group, wherein the polymer segments comprise one or more free-radical-polymerizable monomers. In some aspects, systems are provided that comprise a first composition comprising such a multi-arm polymer and a second composition comprising a multifunctional compound that comprises functional groups that are reactive with the reactive groups of the multi-arm polymer. In some aspects, systems are provided that comprise crosslinked reaction products of such a multi-arm polymer and such a multifunctional compound. | 2022-08-04 |
| 20220243010 | COMPOSITIONS AND ARTICLES INCLUDING PERFLUOROPOLYETHER BOTTLEBRUSH POLYMERS AND METHODS OF MAKING AND USING SAME - This disclosure describes compositions including a perfluoropolyether (PFPE) bottlebrush polymer, optionally blended with other fluoropolymers. The compositions may be disposed on an article, including, for example, a porous filtration media, to form a fluoropolymer-containing article. This disclosure further describes methods of making fluoropolymer-containing articles and methods of using the fluoropolymer-containing articles. | 2022-08-04 |
| 20220243011 | An Amine Functional Compound Having A Urethane Group - An amine functional compound is provided comprising: i. at least one segment consisting of at least one ether unit and at least one ester unit, wherein the ether units and ester units are connected by an ether link or an ester link, and wherein the sum of the number of ether units and ester units is at least three, and wherein the ether units and ester units are arranged in random order, and ii. at least one amine group ii. selected from a tertiary amine group, a salt of a tertiary amine group and a quaternary ammonium group, and wherein each segment i. is covalently linked to the at least one amine group ii. via a linkage comprising an urethane group and another group selected from an urethane group, an urea group, a biuret group and an allophanate group. | 2022-08-04 |
| 20220243012 | POLYMERIC ANION-CONDUCTING MEMBRANE - The present invention provides compounds, especially polymeric compounds, having preferably at least one spiro or piperidine structural unit, a process for preparation thereof and the use thereof as anion conducting membrane. | 2022-08-04 |
| 20220243013 | RESIN COMPOSITION, PREPREG OBTAINED USING SAME, RESIN-COATED FILM, RESIN-COATED METAL FOIL, METAL-CLAD LAMINATE, AND WIRING BOARD - A resin composition includes a modified poly(phenylene ether) compound having a carbon-carbon unsaturated double bond at a molecular end, a maleimide compound having two or more N-substituted maleimide groups in the molecule, and a styrene-based polymer having a weight-average molecular weight less than 10,000. | 2022-08-04 |
| 20220243014 | HYDROLYTICALLY STABLE SELF-HEALING ELASTOMER - The present invention provides a solution-processable self-healing hydrolytically stable elastomer, a method for the preparation thereof, and articles of manufacture comprising the elastomer. The elastomer comprises polymeric chains comprising units of formula (A1), wherein R is a polybutadiene-containing polyurethane; R | 2022-08-04 |
| 20220243015 | SILICONE COMPOSITION THAT CAN BE CROSS-LINKED TO FORM A SILICONE RESIN COMPOSITE MATERIAL - Silicone resin having the general formula | 2022-08-04 |
| 20220243016 | AQUEOUS FORMULATIONS - An aqueous formulation for slick water fracturing includes (i) a polymer (AA) which includes acrylamido repeat units and may be a polyacrylamide; (ii) water; and (iii) a quaternary ammonium compound. | 2022-08-04 |
| 20220243017 | STRESS-RESPONSIVE COMPOSITES - Composite material can include a matrix material, a fiber dispersed in the matrix material, and an ultraviolet (UV)-light sensitive mechanophore grafted to a surface of the fiber. A method for making a fiber-reinforced polymer composite can include contacting a fiber in a first solution, rinsing and then drying intermediate fiber, contacting dried fiber in a third solution, rinsing, and then drying the rinsed fiber thereby generating functionalized fiber that is sensitive to ultraviolet light. The functionalized fiber can be combined with a polymer matrix material, cured, and irradiated, thereby generating a fiber-reinforced polymer composite. | 2022-08-04 |
| 20220243018 | HEAT-SEALABLE POLYESTER FILM - The disclosure discloses a heat-sealable polyester film, including a base layer and a heat-seal layer formed on the base layer. The heat-seal layer includes a physically regenerated polyester resin, a chemically regenerated polyester resin, and a modifier. The heat-sealable temperature of the heat-sealable polyester film is between 100° C. and 230° C. | 2022-08-04 |
| 20220243019 | COMPOSITE PROTON CONDUCTIVE MEMBRANES - A composite proton conductive membrane, comprising an inorganic filler having covalently bonded acidic functional groups and a high surface area of at least 150 m | 2022-08-04 |
| 20220243020 | INSULATING VARNISH COMPOSITION, ROTATING MACHINE COIL AND ROTATING MACHINE - Provided is an insulating varnish composition, including: two or more kinds of epoxy resins; and a filler having an average primary particle diameter of 500 nm or less, wherein the two or more kinds of epoxy resins contain 80 mass % or more of an epoxy resin having a number of repetitions of 0 in a molecular structural formula thereof with respect to a total mass of the two or more kinds of epoxy resins. | 2022-08-04 |
| 20220243021 | POLYMERIC CELL CULTURING SURFACE HAVING HIGH CELL ADHESION - A polymeric substrate has a plasma treated contact surface which is roughened, hydrophilic and has a higher oxygen atomic content than the interior portion. The treated contact surface has an enhanced cell adhesion, cell growth and cell recovery rate. During the treatment, the contact surface is contacted with a process gas introduced through a gas inlet near the treated surface and radio frequency electrical power is introduced in the process gas, forming a treated contact surface that has improved cell recovery compared to an untreated contact surface. The process gas optionally can be nitrogen gas, oxygen gas, or a gas that contains nitrogen atoms, oxygen atoms, or a combination of nitrogen and oxygen atoms. The process optionally improves cell recovery of a chicken embryo cell culture from the treated contact surface. | 2022-08-04 |
| 20220243022 | POROUS COMPOSITE MATERIAL FOR SOUND ABSORPTION AND METHOD OF PRODUCING SAME - A porous composite material ( | 2022-08-04 |
| 20220243023 | CHEMICAL FOAMING OF PVC WITH SURFACE-REACTED CALCIUM CARBONATE (MCC) AND/OR HYDROMAGNESITE - The present invention relates to a PVC resin composition for preparing foamed polymer products, to a foamed polymer product prepared from the composition, to a method for preparing a foamed polymer product, to an article comprising the foamed polymer product as well as to the use of a surface-reacted calcium carbonate, hydromagnesite and mixtures thereof for reducing the density of the obtained foamed PVC product. | 2022-08-04 |
| 20220243024 | METHOD FOR PRODUCING OLEFINIC RESIN POROUS MATERIAL - A novel method for producing an olefinic resin porous material is provided. The method for producing an olefinic resin porous material disclosed herein includes the steps of preparing a single phase in which an olefinic resin and a solvent are mixed each other, in a pressure-resistant container, introducing high pressure carbon dioxide into the pressure-resistant container, and releasing the pressure in the pressure-resistant container. In this method, introducing the high pressure carbon dioxide is carried out such that the pressure in the pressure-resistant container reaches 6 MPa or higher. | 2022-08-04 |
| 20220243025 | METHOD FOR PRODUCING OLEFINIC RESIN POROUS MATERIAL - A novel method for producing an olefinic resin porous material with no skin layer is provided. The method for producing an olefinic resin porous material disclosed herein includes the steps of preparing a single phase in which an olefinic resin, a hydrocarbon compound, and a polar compound are mixed one another, in a pressure-resistant container, introducing high pressure carbon dioxide into the pressure-resistant container, and releasing the pressure in the pressure-resistant container. The polar compound has a hydroxy group or a carbonyl group. Introducing the high pressure carbon dioxide is carried out such that the pressure in the pressure-resistant container reaches 6 MPa or higher. | 2022-08-04 |
| 20220243026 | FOAM FORMULATION - A sprayable water blown low density polyurethane foam-forming formulation including: (A) an isocyanate component; (B) a polyol component, wherein the polyol component includes a surfactant composition; wherein the surfactant composition includes at least one phenol-free secondary alkyl alcohol ethoxylate, and wherein the at least one phenol-free secondary alkyl alcohol ethoxylate is at least one linear alkyl chain phenol-free secondary alcohol ethoxylate; and (C) water; a process for making the above sprayable water blown low density polyurethane foam-forming formulation; and a polyurethane foam made from the above sprayable water blown low density polyurethane foam-forming formulation. | 2022-08-04 |
| 20220243027 | Extraction Materials for In-Situ Consolidation and Multi-Packaging of Underwater Fragile Cultural Relics, and Extraction and Restoration Methods - The present disclosure discloses extraction materials for in-situ consolidation and multi-packaging of underwater fragile cultural relics, and extraction and restoration methods. | 2022-08-04 |
| 20220243028 | METHOD FOR RECYCLING POLYSTYRENE AND SOLVENT FOR DISSOLVING POLYSTYRENE - A method for recycling polystyrene in a dissolution recycling process, in which method 1,3-dioxolane or isoamyl acetate is used as a solvent for dissolving polystyrene. | 2022-08-04 |
| 20220243029 | BLACK POLYESTER FILM AND METHOD FOR MANUFACTURING THE SAME - A black polyester film and a method for manufacturing the same are provided. The method for manufacturing the black polyester film includes: providing a recycled polyester material; physically regenerating a part of the recycled polyester material to form physically regenerated polyester chips having a first intrinsic viscosity; chemically regenerating another part of the recycled polyester material to form chemically regenerated polyester chips having a second intrinsic viscosity lower than the first intrinsic viscosity; mixing black regenerated polyester chips, the physically regenerated polyester chips, and the chemically regenerated polyester chips according to a predetermined intrinsic viscosity so as to form a polyester chip raw material; melting and then extruding the polyester chips raw material to form the black polyester film having the predetermined intrinsic viscosity. | 2022-08-04 |
| 20220243030 | WHITE POLYESTER FILM AND METHOD FOR MANUFACTURING THE SAME - A white polyester film and a method for manufacturing the same are provided. The method for manufacturing the white polyester film includes: providing a recycled polyester material; physically regenerating a part of the recycled polyester material to form physically regenerated polyester chips having a first intrinsic viscosity; chemically regenerating another part of the recycled polyester material to form chemically regenerated polyester chips having a second intrinsic viscosity less than the first intrinsic viscosity; mixing white regenerated polyester chips, the physically regenerated polyester chips, and the chemically regenerated polyester chips according to a predetermined intrinsic viscosity so as to form a polyester masterbatch material; melting and extruding the polyester masterbatch material to obtain the white polyester film having the predetermined intrinsic viscosity. | 2022-08-04 |
| 20220243031 | MATTE POLYESTER FILM AND METHOD FOR MANUFACTURING THE SAME - A matte polyester film and a method for manufacturing the same are provided, The method for manufacturing the matte polyester film includes: providing a recycled polyester material; physically regenerating a part of the recycled polyester material to form physically regenerated polyester chips having a first intrinsic viscosity; chemically regenerating another part of the recycled polyester material to form chemically regenerated polyester chips having a second intrinsic viscosity less than the first intrinsic viscosity; mixing matte regenerated polyester chips, the physically regenerated polyester chips, and the chemically regenerated polyester chips according to a predetermined intrinsic viscosity so as to form a polyester masterbatch material; melting and then extruding the polyester masterbatch material to obtain the matte polyester film having the predetermined intrinsic viscosity. | 2022-08-04 |
| 20220243032 | POLYESTER FILM AND METHOD FOR PRODUCING THE SAME - A polyester film and a method for producing the same are provided. The polyester film includes a physically recycled polyester resin and a chemically recycled polyester resin. The physically recycled polyester resin is formed of physically recycled polyester chips, and the physically recycled polyester chips have a first intrinsic viscosity. The chemically recycled polyester resin is formed of chemically recycled polyester chips, and the chemically recycled polyester chips have a second intrinsic viscosity. The second intrinsic viscosity is less than the first intrinsic viscosity. The physically recycled polyester chips and the chemically recycled polyester chips are mixed with each other and melt extruded according to a predetermined intrinsic viscosity, so that the polyester film has the predetermined intrinsic viscosity. | 2022-08-04 |
| 20220243033 | CELLULOSE RESIN COMPOSITION, MOLDED BODY AND PRODUCT USING SAME - The present invention provides a cellulose resin composition capable of forming a molded body having high-quality appearance and scratch resistance. A cellulosic resin composition including a cellulose derivative, a lubricant, and a plasticizer, wherein the cellulose derivative is an acylated cellulose obtained by substituting at least a part of hydrogen atoms of hydroxy groups of a cellulose with an acetyl group, the content of the lubricant is in the range of 0.1 to 10% by mass, the plasticizer comprises an adipic acid mixed ester composed of adipic acid and diethylene glycol monomethyl ether and benzyl alcohol, and the content of the plasticizer is in the range of 5 to 70 parts by weight with respect to 100 parts by weight of the cellulose derivative (A). | 2022-08-04 |
